Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
LOADING
|||
PB Ratio: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-book ratio
Latest
0.64
↓ 91% below average
Average (6y)
7.51
Historical baseline
Range
High:16.91
Low:0.64
CAGR
-42.1%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 0.64 | -71.8% |
| 2023 | 2.27 | -7.7% |
| 2022 | 2.45 | -75.1% |
| 2021 | 9.86 | +42.7% |
| 2020 | 6.91 | -48.9% |
| 2019 | 13.51 | -20.1% |
| 2018 | 16.91 | - |